PreImplantation Factor (PIF) correlates with early mammalian embryo development-bovine and murine models by Stamatkin, Christopher W et al.
RESEARCH Open Access
PreImplantation Factor (PIF) correlates with early
mammalian embryo development-bovine and
murine models
Christopher W Stamatkin
1, Roumen G Roussev
1, Mike Stout
2, Victor Absalon-Medina
3, Sivakumar Ramu
1,
Chelsi Goodman
1, Carolyn B Coulam
1, Robert O Gilbert
3, Robert A Godke
2 and Eytan R Barnea
4,5*
Abstract
Background: PreImplantation Factor (PIF), a novel peptide secreted by viable embryos is essential for pregnancy:
PIF modulates local immunity, promotes decidual pro-adhesion molecules and enhances trophoblast invasion. To
determine the role of PIF in post-fertilization embryo development, we measured the peptide’s concentration in
the culture medium and tested endogenous PIF’s potential trophic effects and direct interaction with the embryo.
Methods: Determine PIF levels in culture medium of multiple mouse and single bovine embryos cultured up to
the blastocyst stage using PIF-ELISA. Examine the inhibitory effects of anti-PIF-monoclonal antibody (mAb) added
to medium on cultured mouse embryos development. Test FITC-PIF uptake by cultured bovine blastocysts using
fluorescent microscopy.
Results: PIF levels in mouse embryo culture medium significantly increased from the morula to the blastocyst
stage (ANOVA, P = 0.01). In contrast, atretic embryos medium was similar to the medium only control. Detectable -
though low - PIF levels were secreted already by 2-cell stage mouse embryos. In single bovine IVF-derived
embryos, PIF levels in medium at day 3 of culture were higher than non-cleaving embryos (control) (P = 0.01) and
at day 7 were higher than day 3 (P = 0.03). In non-cleaving embryos culture medium was similar to medium alone
(control). Anti-PIF-mAb added to mouse embryo cultures lowered blastocyst formation rate 3-fold in a dose-
dependent manner (2-way contingency table, multiple groups, X2; P = 0.01) as compared with non-specific mouse
mAb, and medium alone, control. FITC-PIF was taken-up by cultured bovine blastocysts, but not by scrambled
FITC-PIF (control).
Conclusions: PIF is an early embryo viability marker that has a direct supportive role on embryo development in
culture. PIF-ELISA use to assess IVF embryo quality prior to transfer is warranted. Overall, our data supports PIF’s
endogenous self sustaining role in embryo development and the utility of PIF- ELISA to detect viable embryos in a
non-invasive manner.
Background
The viable mammalian embryo controls its own destiny,
transmitting specific signals to the mother/host through-
out pregnancy [1]: Within the uterus, such signals sup-
port implantation [2] while in the periphery they induce
and/or maintain tolerance without allowing for deleter-
ious immune suppression to occur [3]. Evidently, accep-
tance signals by the mother also play an important role.
Since the immune milieu of pregnancy is unique - not
replicated in any other circumstances - specific embryo-
derived signals have a crucial role leading to maternal
recognition of pregnancy [4]. To orchestrate such criti-
cal ‘cross-talk’,aviable embryo must be present, which
may be accepted by the mother, whereas, a non-viable
conceptus will fail to develop or later be rejected since
maternal acceptance does not occur. The search to iden-
tify embryo-specific markers which reflect viability of
cultured embryos by assessing the medium or by per-
forming an embryo biopsy (beyond morphological
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marker has entered into routine clinical use in humans
or other mammals undergoing IVF procedures [5,6].
In humans, the platelet activating factor - (PAF) [7]
and early pregnancy factor-(EPF) [8] have not been pro-
ven useful in selecting the best embryos for transfer to
the recipient. Soluble HLA-G (sHLA-G) also failed to
confirm its proposed utility in clinical studies [9]. Mea-
surement of free radicals in the culture medium of
developing embryos has been reported as an index for
embryo viability. However, it is not an embryo-specific
marker and the fate of the transferred embryo cannot
be followed in maternal circulation [10].
The Barnea group reported that viable mouse and
human embryos secrete a peptide, PreImplantation Fac-
tor (PIF) (MVRIKPGSANKPSDD), which is present in
maternal circulation and is expressed by embryos and
placental tissue [4,11-14]. In the placenta, PIF was found
to be expressed in the trophoblastic layer in the first and
second trimester while minimally being expressed at
term as documented by staining using a specific anti-
PIF-antibody [13]. Synthetic PIF analog (sPIF) replicates
native PIF action, modulates peripheral immune cells to
achieve tolerance without immune suppression, and has
been demonstrated to be effective in autoimmunity
models outside pregnancy [15-17]. PIF displays essential
multi-targeted effects; regulating immunity, promoting
embryo-decidual adhesion, and regulating adaptive
apoptotic processes in cultured human decidual cells
[18]. In addition, PIF promotes trophoblast invasion
reflecting an autocrine supporting effect on conceptus
development [19]. We have previously demonstrated
that PIF is secreted by viable embryos [13]. Therefore, it
is important to determine whether monitoring PIF levels
in embryo culture medium could be of value in deter-
mining embryo developmental potential reaching to the
blastocyst stage. Further, since PIF is an early secretory
product, determining whether the peptide has embryo
trophic effects could further substantiate its role in early
pregnancy events.
Since access to large quantities of culture medium from
human IVF embryos is limited (single embryos are cul-
tured in low volumes), it was decided to examine PIF
secretion into the medium using our ELISA methods in
two different species offering complementary features. In
mice, a large number of embryos can be cultured
together which enables measurements of an expected low
PIF level in the medium. Bovine embryos (larger size) can
be successfully cultured singly to assess the source of PIF
production by individual embryos. The single bovine
embryo cultures serve as an IVF model where serial mea-
surements of secreted products also can be determined.
The aims of the study were: 1. Determine PIF levels by
ELISA in the medium of post-fertilization mouse
embryos cultured up to the blastocyst stage. 2. Measure
P I Fl e v e l sb yE L I S Ai nt h em e d i u mo fc u l t u r e ds i n g l e
bovine IVF embryos. 3. Test the inhibitory effect of anti-
PIF-monoclonal antibody added to cultured mouse
embryos. 4. Examine FITC-PIF uptake by cultured bovine
blastocysts. We report that PIF is secreted by viable
bovine and mouse embryos and we suggest that the pep-
tide has a supporting role in embryo development.
Methods
Biotin-conjugated mouse anti-PIF mAb, (proprietary of
BioIncept LLC) horseradish peroxidase (HRP)-conjugated
streptavidin (UltraAvidin-HRP), antigen-coating buffer
and tetramethylbenzidine (TMB) substrate were all
obtained from Leinco Technologies, Inc. (Saint Louis,
MO). SEA BLOCK blocking buffer was obtained from
Thermo Scientific (Waltham, MA). LumiGLO Peroxidase
C h e m i l u m i n e s c e n ts u b s t r a t ew a so b t a i n e df r o mK P L ,
Inc. (Gaithersburg, MD). Synthetic PIF (MVRIKPG-
SANKPSDD) and scrambled PIF (GRVDPSNKSMPKDIA)
(proprietary of BioIncept LLC) were obtained by solid-
phase peptide synthesis (Peptide Synthesizer, Applied Bio-
systems, Foster City, CA) using Fmoc (9-fluorenylmethox-
ycarbonyl) chemistry. The same peptides were also labeled
with FITC on their N-termini in the solid phase after the
addition of l-alanine as a spacer group. Final purification
was conducted by reversed-phase HPLC and identity was
verified by MALDI-TOF mass spectrometry and amino
acid analysis. Ovalbumin-conjugated PIF was also gener-
ated. (Biosynthesis, Inc., Lewisville, TX).
Mouse embryo cultures
The study has been approved by Cari Research Institute.
A routinely used mouse embryo culture procedure was
used in this study [11,12]. 2-cell embryos were collected
from super ovulated mated CB6F1/J mice. Removed ovi-
ducts were dissected under microscope and embryos
removed in mHTF medium (n = 10 to110/well) and cul-
tured in using 4 well (176740) and 24 well (142475)
Nunc well plates in 500 μl droplets of culture medium
(5% Quinns advantage blastocyst medium, RM-ART-
1029 in 95% mHTF), Cat No 90125 (Irvine Bio, CA)
and 10% FBS under mineral oil by incubating at 37°C
with 5% CO2 for 3 days, at a pH 7.2 which was main-
tained throughout the culture period. In the first set of
experiments, mouse embryos were cultured serially from
the morula stage (15 dishes with 10 morula each) to the
blastocyst stage (15 dishes with 10 blastocysts each) and
PIF levels were compared with atretic embryos (those
embryos that degenerated and failed to progress beyond
the 2-cell stage). (8 dishes with 10 embryos each) or cul-
ture medium alone, used as control. In the second set of
experiments to determine how early PIF is secreted,
2-cell stage embryos (102-110/well) were collected and
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lected. In the third set of experiments embryos
(10 to15/group) were cultured in 100 μld r o p l e t sf o r
72 hours up to the blastocyst stage and PIF levels in the
medium were determined and compared with medium
alone (control). The data were calculated as estimated
amount total in culture as well as estimated by indivi-
dual embryos.
In vitro fertilization procedure to retrieve bovine oocytes
The study has been approved by the Louisiana State
University. At the Louisiana State University Embryo
Biotechnology Laboratory, in vitro fertilization (IVF) was
performed on bovine oocytes obtained from a commer-
cial source (Ovitra, TX). Oocytes arrived in a climate
controlled container via FedEx at ~24 hours following
their collection. A standard bovine IVF laboratory pro-
cedure was performed on groups of 10 oocytes in 40 μl
droplets of fertilization medium (IVF-TALP). Briefly,
2 μl of heparin (2 μg/ml), 2 μlo fP H Ea n d2μls p e r m
were added to each fertilization droplet with the M-II
oocytes. This made the total medium volume 44 μl. Fro-
zen-thawed sperm from a fertile Holstein bull was used
in all bovine IVF experiments. The in vitro fertilization
interval was 18 hours incubated in a humidified atmo-
sphere of 5% CO2 in air at 39°C.
Following fertilization, the presumptive zygotes were
removed from the fertilization droplets and treated with
hyaluronidase (1 mg/ml) to remove the remaining cumu-
lus cells. The embryos were then washed in HEPES-
TALP medium and transferred to CR1aa medium [20]. A
single embryo from the group of IVF-derived embryos
was then placed into a fresh 40 μl droplet of CR1aa cul-
ture medium at 39°C in a humidified atmosphere of 5%
CO2 in air. On day 3 of culture, individual embryos were
transferred to a new 40 μl droplet of CR1aa and incu-
bated at 39°C in a humidified atmosphere of 5% CO2 in
air and were cultured in the same medium until day 7 of
culture. At the end of the experiment, embryos were
assigned an embryo quality grade (1 = good to 3 = poor)
and evaluated for morphological development (2-cell
stage through to the blastocyst stage).
PIF secretion in IVF-derived bovine embryos during in
vitro culture
IVF was performed on M-II bovine oocytes (n = 116). Fol-
lowing fertilization, single normal appearing zygotes were
then placed into an individual 40 μl droplet of CR1aa cul-
ture medium [21] (n = 120). On day 3 of culture, embryos
were transferred to a new 40 μl droplet of CR1aa medium
for days 3 to 7 of in vitro culture. Only embryos that
showed morphological development were transferred to
fresh individual culture droplets. Morphological develop-
ment of the embryos on days 1, 3 and 7 was recorded just
prior to being moved to a fresh culture medium. After the
embryos were moved from the 40 μl droplets, two 10 μl
samples of conditioned culture medium from day 3 and
day 7 culture were collected and frozen for subsequent
determination of PIF concentrations using a PIF- ELISA
described below.
Neutralize endogenous PIF using anti-PIF monoclonal
antibody
An anti-PIF monoclonal antibody was developed (Gen-
way, Inc. San Diego, CA.) and its specificity was subse-
quently validated (see ELISA methods). Mouse 2-cell
stage embryos (n = 19-36/group) were cultured with
increasing antibody concentrations (0.047-47 μg/ml).
After culturing for 72 hours, the number of embryos
that developed at each morphologic stage was
recorded. Embryo quality and in vitro survival were
evaluated from the 2-cell stage through the blastocyst
stage. Also, the number of atretic embryos following
exposure to each treatment was noted. These results
were compared with exposure to the non-specific
mouse anti-IgG isotype monoclonal antibody (Zymed,
San Francisco, CA) that served as the negative control
and culture medium alone that served as an additional
control.
PIF-ELISA methods: sandwich PIF-ELISA
Affinity purified anti-PIF Ab (rabbit IgG, Covance
Laboratories, PA) in bicarbonate buffer (pH 9.0) was
diluted 1:2000 and 100 μl of the solution was added to
96 -well plates, incubated for 1 hour at 37°C and then
refrigerated overnight at 4°C, then washed three times
with PBS. Each plate was blocked with 100 μl0 . 2 %o f
nonfat dry milk in PBS and incubated for one hour at
room temperature followed by washing with PBS. Either
50 μl mouse embryo culture medium or 50 μl PIF stan-
dards (0.007 to 1 μg/ml) was added to plates. Following
1 hour incubation, plates were washed with PBS. Then
100 μl of anti-PIF monoclonal antibody at 1:4000 in
PBS was added and incubated for 1 hour followed by
washing with PBS. 100 μl conjugated goat anti-mouse
IgG alkaline phosphatase (Pierce, Rockford, IL) was
a d d e da n di n c u b a t e df o r1h o u rf o l l o w e db yw a s h i n g
with PBS. 100 μl substrate buffer (p-nitrophenyl)
(Pierce) was added and the reaction was stopped after
15-20 minutes with 70 μl3 MN a O H .As t a n d a r dc u r v e
is shown (see Additional file 1, Figure S1). Also the
anti-PIF-monoclonal antibody properties that are pro-
vided comparing PIF binding as compared with
scrambled PIF (no binding) (see Additional file 2, Figure
S2). The affinity of anti-PIF-monoclonal antibody to PIF
is shown (see Additional file 3, Figure S3). The serial
mouse embryo culture data was generated with the
sandwich assay.
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Briefly, ovalbumin-PIF was diluted in Ultracoat II buffer
(100 ng/ml) and 100 μl was added to each well of 96
well-plate, incubated overnight, washed and blocked
with 300 μl of SEA BLOCK buffer for 2 hours at 37°C,
then washed and air dried. Both mouse and bovine
embryo culture medium were diluted in PBS, 1:2 or
with duplicate sPIF standards (1to1,250 ng/ml) and 50
μl of the medium was added to 50 μlo fb i o t i n - a n t i - P I F
mAb solution, (1:20,000), except for the blanks. Follow-
ing incubation for 2 hours, wells were washed, 100 μl
UltraAvidin-HRP was added and incubated for 30 min-
utes at 37°C. After washing, 100 μlL u m i G L Ow a s
added to each well for 5 minutes and plates were read
in a SpectraMax L microplate luminometer and ana-
lyzed using SoftMax Pro software (Molecular Devices,
Sunnyvale, CA). Assay linearity and anti-PIF-monoclonal
antibody specificity are shown (Figure 1). Background
assay levels were 10 ng/ml tested with several different
serum-free embryo culture medium also used in the pre-
sent study. Assay readings were linear down to 2 ng/ml.
Spike and recovery experiments at 30 ng/ml and 70 ng/ml
confirmed recovery at 95% and 115%, respectively. The
early mouse embryo and blastocyst data as well as all
the bovine embryo data was generated using the chemil-
luminescent ELISA.
Studies for FITC-PIF uptake by bovine blastocysts: Oocyte
recovery and selection
The study has been approved by Cornell University
College of Veterinary Medicine. Ovine ovaries were col-
lected at nearby abattoir and transported to the labora-
tory in prewarmed lactated Ringer’s solution at 30-35°C.
Cumulus oocyte-complexes (COCs) from 2-8 mm folli-
cles were aspirated with an 18G hypodermic needle
attached to an aspiration pump unit adjusted to a pres-
sure of 22.5 ± 2.5 ml of H2O per minute. Follicular fluid
supernatant was removed and the pellet containing
COCs was transferred to a 15 ml tube where it was
resuspended with holding media and contents were
poured gently into a 100 mm Petri dish. Holding media
consisted on TCM-199 Hank’s salts (Invitrogen []) 10%
Figure 1 PIF detection in viable embryo culture medium using anti-PIF-mAb-based chemiluminescent ELISA.R e p r e s e n t a t i v es t a n d a r d
curve of PIF ELISA demonstrates that low levels of the peptide can be detected. The assay was linear where 2 ng/ml was the lowest detection
limit.
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heparin 4 μg/ml (sigma) with a mOsm = 300 ± 1. Mor-
phological selection of COCs consisted of using only
those showing several layers of granulosal cumulus cells
and oocytes with a homogenous cytoplasm.
In vitro maturation
S e l e c t e dC O C sw e r em a t u r e di ng r o u p so f4 0±5f o r
23 ± 1 hours in 400 μLo fT C M - 1 9 9( E a r l e ’sS a l t s
[Sigma M2154]) enriched with 10% fetal calf serum
( F C S ;I n v i t r o g e n ) ,2 2μg/ml sodium pyruvate, 1 mM
alanyl-glutamine, 0.1 mM taurine, 0.1 mM cysteamine,
1 μg/ml estradiol, 5 μg/ml luteinizing hormone (LH;
SIOUX Biochemical, Inc., Sioux Center, IA), 0.5 μg/ml
follicle stimulating hormone (FSH; SIOUX), 10 ng/ml
epidermal growth factor (EGF; BD Biosciences–Discov-
ery Labware, MA), 25 μg/ml gentamicin, pH 7.35 ±
2a n dm O s m3 0 0±2c o v e r e dw i t hm i n e r a lo i li na
humidified atmosphere at 38.5°C with 5% CO2 in air.
In vitro fertilization
After a total of 23 ± 1 hours presumptive matured
oocytes were transferred to a modified IVF medium
(Fert-TALP) [20] supplemented with 0.5 mM fructose,
6 mg/ml BSA FFA Fraction V, 30 μM penicilamine,
15 μMh y p o t a u r i n e ,1 . 5μM epinephrine (PHE), 22 μg/ml
heparin, covered with mineral oil in a humidified atmo-
sphere at 38.5°C with 5% CO2 in air for 18-22 hours
(pH of 7.38 ± 1, mOsm 290 ± 2). Frozen semen sam-
ples from a single bull were thawed and sperm was
separated from the seminal plasma and cryoprotectant
by percoll step gradient (90, 45%) centrifugation at
700 × g for 20 min. Subsequently, sperm was washed
twice in 5 ml of TL-Semen (pH 7.39 ± 1, mOsm 295 ±
2) at 300 × g for 5 min to remove Percoll. Finally,
sperm was adjusted to a final concentration of 1.5 ×
10
6 sp/ml and with an average progressive motility of
50% using Fert-TALP media.
In vitro embryo culture
A modified synthetic oviductal fluid (SOF) [22] media
was used for the in vitro embryo culture (pH 7.4 ± 1,
mOsm 275 ± 5). After fertilization, putative zygotes
were denuded at maximum vortex for 120 seconds and
transferred to a modified SOF (SOF early) supplemented
with 10 μM EDTA, 0.5 mM fructose, 4 mg/ml BSA FFA
Fraction V, 0.1 mM taurine, and without essential
amino acids covered with mineral oil in a humidified
atmosphere at 38.5°C with 5% CO2,5 %O 2,a n d9 0 %N 2
in air for ~48 hours. After that time, cleavage rates were
assessed and embryos were transferred to new droplets
containing SOF mid, which was supplemented with
essential and non-essential amino acids, 4 mg/ml BSA
FFA Fraction V, and 0.5 mM glucose in a humidified
atmosphere at 38.5°C with 5% CO2,5 %O 2,a n d9 0 %N 2
in air for ~96 hours. Embryos were transferred to fresh
SOF mid droplets under the same conditions after the
first ~48 hours. Finally, d-7 embryos were transferred
for the last ~24 hours of culture to SOF late, which was
SOF supplemented with 5% fetal calf serum (FCS),
0.1 mM taurine and 0.5 mM glucose in a humidified
atmosphere at 38.5°C with 5% CO2,a n d5 %O 2,a n d
90% N2 in air. Further, blastocyst rates were based on
percentages of the original oocyte number.
FITC-PIF uptake by bovine blastocysts
After eight days post-fertilization, embryos were sorted
by stage (i.e. blastocyst, expanded blastocyst and hatched
blastocyst) (N = 23) and cultured for 30 minutes in syn-
thetic oviductal media droplets containing 5 μg/ml
FITC-PIF or FITC-PIFscrambled in a humidified atmo-
sphere, 5% CO2,5 %O 2 and balanced N2 with a tem-
perature 38.5°C. Blastocysts were counterstained with
DAPI (diamidino-2-phenylindole) a blue fluorescent
probe that fluoresces brightly upon selectively binding
to the minor groove of double stranded DNA, (nuclear)
where its fluorescence is approximately 20-fold greater
than in the non-bound state. Subsequently, blastocysts
were washed in PBS/PVP solution to remove non-
specific binding and fixed in 10% formalin containing
0.1% triton x-100. Fixed embryos were mounted on
slides with two etched 10 mm diameter circles sur-
rounded by white ceramic ink, embryos were covered
with glycerol containing Hoechst 33348 (3 μg/ml).
Image acquisition
All slides were visualized using a microscope (Imager
Z1; Carl Zeiss, Inc.) under a 20 × 0.5 NA ECPlan Neo-
fluar air immersion (Carl Zeiss, Inc.). The fluorochromes
used FITC and nuclei were observed using DAPI filter.
Slides were excited at 340 nm and 488 nm to visualize
DAPI nuclear stain and FITC, respectively. Images were
captured with a cooled charged-coupled device camera
(AxioCam MRm; Carl Zeiss, Inc.) and processed using
AxioVision software (version 4.7.2; Carl Zeiss, Inc.).
Images untouched were taken as superimposed (FITC/
DAPI), FITC and DAPI, alone.
Statistical Analysis
PIF secretion by mouse embryo cultures and by cow
embryos was analyzed by ANOVA followed by paired
Student’s t-test. The proportion of mice embryos that
were affected by exposure to anti-PIF monoclonal anti-
body was determined using a 2-way contingency multi-
group Chi square analysis. Analysis was carried out
using Analyse-it for Microsoft Excel. A P < 0.05 level
was considered to be significantly different in these
studies.
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PIF is secreted by viable embryos
The dynamics of PIF secretion by cultured mouse embryos
was assessed. We showed that PIF was detected in the
medium of morula stage embryos cultured in groups and
PIF levels further increased in the blastocyst stage in seri-
ally cultured embryos (ANOVA, P = 0.05 and P = 0.01),
respectively as compared with controls. (Figure 2). In con-
trast, PIF secretion by atretic embryos was minimal with
values that were similar to medium alone. Thus, increased
PIF levels reflect progressive embryo development.
PIF secretion starts at the 2-cell stage
How early post-fertilization is PIF secreted? Two-cell
stage mouse embryos (n = 102-110) were cultured in
vitro for only 4 hours. Measurable (but low) PIF levels
were detected by using our sensitive chemiluminescent
ELISA (Table 1). In embryos cultured up to the blasto-
cyst stage, (10-15/group) PIF levels were higher. Per
embryo, PIF appeared to be ~10-12 fold higher in blas-
tocysts than in 2-cell embryos. Hence, PIF is a secreted
product of early stage embryos and levels are higher at a
later developmental stage.
PIF is secreted by viable individual IVF derived embryos
(bovine)
We examined the pattern of PIF secretion by individual
IVF derived bovine embryos in culture. It is recognized
that in the bovine species cultured, single embryos fre-
quently do not progress to the blastocyst stage and
many embryos will fail to cleave. For analysis we used
PIF values (Mean+/-SEM) of developing embryos com-
paring the levels in the same embryos at day 3 to levels
present at day 7. Those embryos that degenerate cul-
tured from day 3 to 7, showing no change, and those
that fail to cleave used as control. We found that PIF
levels increased significantly from day 3 to day 7 in the
culture medium, and in developing single embryo cul-
tures (ANOVA, P = 0.03). The difference between day 3
cleaving embryos and the control (non-cleaving
embryos, or medium used as background control) at day
3 of culture were significantly different (P = 0.01). In all
embryos, a microphotograph was taken to compare the
morphology to PIF levels (Figure 3). Individual embryo’s
PIF levels ng/ml at day 3 were as follows: 6 cells (10.7),
8 cells (12.6-18.2), day 7; 32 cells (16.3) morula (13.3-
26.8) and blastocyst (21.3). PIF was already detected at
Mean +/-S E M
Media                10 Morula                  10 Blastocysts             10 Atretic embryos
ng/ml
0
1
2
3
4
5
6
7
8
*
* *
Figure 2 PIF detection in culture medium was associated with mouse embryo viability. Mouse embryos were cultured in groups up to
the morula stage medium collected and further cultured up the blastocyst stage collecting the medium. PIF levels were compared with
cultured atretic embryos and medium control. Data are expressed mean+/-SEM. PIF levels were significantly higher in both morulae and
blastocysts (p = 0.05 and p = 0.01) respectively, as compared to similar levels obtained in atretic and medium alone used as control.
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up to the blastocyst stage. All PIF levels in viable embryos
were significantly higher than medium only control. In
contrast, PIF concentration in medium of cow embryos
that failed to develop at day 3 (9.7+/-1.8) (N = 5) or even
at day 7 (11.2+/- 1.4 (N = 5) were similar to levels in
medium of non-cleaving embryos or media alone (back-
ground levels (control) Mean+/- SEM 10+/-1 (N = 15)),
(P = 0.87, NS). (Figure 4) Microphotographs of represen-
tative cow embryos are shown (N = ~100) (Figure 5).
Therefore, increasing levels of PIF in cultured IVF bovine
embryos correlate with their development.
Endogenous PIF is a requirement for early embryo
development
Since PIF is secreted shortly post-fertilization (2-cell
stage) in mice, we examined endogenous peptide’s poten-
tial role in controlling mouse embryos development.
Addition of anti-PIF antibody to cultures significantly
reduced mouse blastocyst formation rates as compared
with the total number of cultured embryos (Table 2). All
anti-PIF-mAb doses tested reduced blastocyst formation
and increased rates of atretic and 2-cell embryos as com-
pared with the controls 2-way contingency table, multiple
groups, (X
2;P = 0.01). At the highest anti-PIF-mAb con-
centration (47000 ng/ml) blastocyst rates were only 21%
while atretic embryo rates were elevated 63%. The effect
was dose-dependent; at the lowest antibody concentra-
tion 47 ng/ml blastocyst rates were higher (41%) and
atretic rates were lower (34%) as compared with the high-
est antibody concentration tested (X
2,P=0 . 0 3 ) .I nc o n -
trast, in both tested control groups the non-specific
mouse antibody and medium control blastocyst rates
were significantly higher than any anti-PIF antibody
Figure 3 PIF detection in single cultured bovine IVF embryos
medium. PIF levels increase in viable embryos. Cleaving
embryos were cultured from day 3 to day 7 reaching up to the
blastocyst stage. PIF levels Mean+/- SEM in the medium were
significantly higher compared with levels in non-cleaving embryos
(ANOVA followed by student t-test): Control (medium alone, or
medium of non-cleaving embryos (n = 15) vs. day 3 P = 0.01,
Control vs. day 7, P = 0.005, Day 3 vs. day 7, P = 0.03).
Table 1 PIF secretion by mouse embryos at day 0 and
day 3 of culture
Day 0 Day 3
3.2 26.2
56.4 35.4
23.1 83.9
9.5 33.6
34.5
50.1
62.6
Mean +/-SEM 23.7+/-13.5 46.6+/-7.7
Mouse embryos were cultured at 2-cell stage for 4 hours (N = 102-110/
embryos) and the media was collected for analysis from 4 different culture
media and analyzed for PIF levels. Also, mouse embryos were cultured at 2-
cell stage (N = 10-15/embryos) for 72 hours and the media was collected for
PIF analysis from 7 different cultures. Results are mean values+/- SEM of
results of independent cultures. Chemiluminescent ELISA. Background levels
were substracted from each experiment. Data is expressed as ng/ml.
Figure 4 PIF levels in atretic embryos are similar to non-
cleaving embryos. The medium collected from embryos that failed
to progress from day 3 to day 7 of culture were analyzed
sequentially and levels Mean+/-SEM were compared with non-
cleaving embryos. There were no significant differences among the
groups tested (n = 5-15/group).
Figure 5 Microphotographs of individually cultured viable and
non-viable bovine IVF embryos. It shows a representative group
of bovine embryos cultured from the 6-cell to blastocyst stage,
which were used to determine PIF levels in their culture medium as
well a non- cleaving embryo, control.
Stamatkin et al. Reproductive Biology and Endocrinology 2011, 9:63
http://www.rbej.com/content/9/1/63
Page 7 of 11concentration tested 77% and 68%, respectively. Also no
atretic embryos were observed in the two control groups
(X
2, P = 0.01, multigroup). Hence, endogenous PIF is
required to support optimal embryo (blastocyst) develop-
ment in the mouse.
FITC-PIF is being uptaken by cow blastocysts
Since PIF secretion correlated with cow embryo devel-
opment. We aimed to examine whether PIF also being
uptaken by those embryos in culture. We found that
after culturing blastocysts with FITC-PIF significant
uptake was noted (Figure 6A, B, C, D). The binding was
documented in blastocysts, expanded blastocysts and
hatched blastocysts. In contrast, scrambled FITC-PIF,
failed to bind (control). However, the FITC-PIF uptake/
staining was not specific for the ICM/TB cells as all
cells appeared to be labeled.
Discussion
PreImplantation Factor is secreted by viable embryos
(absent in non-viable embryos) and has been reported
to play an essential role in early pregnancy events:
Table 2 Anti-PIF-antibody reduces mouse embryos blastocyst development
Anti-PIF Mab Titration N = 24 26 36 27 30 19
47000 ng/mL % 4700 ng/mL % 470 ng/mL % 47 ng/mL % Neg. Contr. % Isotype Contr. %
Blastocyst 5 0.21 8 0.31 11 0.32 11 0.41 23 0.77 13 0.68
Eblast 2 0.08 2 0.08 7 0.21 4 0.15 5 0.17 3 0.16
Morula 2 0.08 0 0.00 4 0.12 0 0.00 2 0.07 2 0.11
6-8 cell 0 0.00 7 0.27 2 0.06 3 0.11 0 0.00 0 0.00
2-4 cell 11 0.46 5 0.19 11 0.32 8 0.30 0 0.00 1 0.05
AT > Morula 0 0.00 2 0.08 0 0.00 0 0.00 0 0.00 0 0.00
AT < Morula 4 0.17 2 0.08 1 0.03 1 0.04 0 0.00 0 0.00
Mouse 2cell embryos were collected from mice and cultured with increasing concentrations of anti-PIF-antibody added to the culture media. (N = 19-36/group).
Results were compared with isotype antibody and medium alone used as controls. Data is expressed as number of embryos in each developmental stage.
Inhibitory effect of anti-PIF-antibody was dose dependent. Data analyzed by using (2-way contingency table, multiple groups, (X
2; P = 0.01).
Figure 6 FITC-PIF is selectively taken up by bovine blastocysts. Blastocysts were exposed to either 5 μg/ml FITC-PIF or scrambled FITC-PIF
for 30 minutes in culture and specific binding was evaluated by washing off unattached fluorescent peptide. Blastocysts nuclei were also
counterstained using DAPI, vital stain. Embryos were fixed, stained and evaluated by using a fluorescent microscope using two different wave
lengths. b+c (FITC-PIF or scrambled FITC-PIF and DAPI stain), b, (FITC-PIF or scrambled FITC-PIF alone), c (DAPI stain alone). Part A: FITC-PIF binds
to cultured blastocysts. Part B: FITC-PIF binds to expanded blastocysts. Part C: FITC-PIF binds to hatched blastocysts Part D. In contrast, 5 μg/ml
FITC-scrambled PIF, used as control did not bind. (magnification × 40).
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implantation starting shortly post-fertilization [18,19].
We demonstrate herein that PIF is secreted by both
viable mouse and bovine IVF embryos, indicating that
the peptide may serve as a universal embryo viability
marker. PIF secretion starts shortly post-fertilization,
detected as early as the 2-cell stage, and reflects PIF’s
critical role in the earliest stages of mammalian embryo
development. Neutralization of endogenous PIF effect
reveals that the peptide is needed for embryos to pro-
gress to the blastocyst stage, since PIF exerts an obliga-
tory direct supportive role. Hence, PIF-ELISA is an
effective method to assess non-invasively the viability of
cultured embryos at the earliest developmental stages
and correlate PIF levels with their potential reaching the
blastocyst stage. PIF-ELISA may thus represent a reli-
able tool to facilitate IVF embryo selection for transfer
into the maternal host.
PIF was already detected at the 2-cell stage in mouse
embryo culture medium. This confirms our previous
results on PIF activity in both mouse and human
embryo culture medium [14,23]. However, as expected
given the limited secretion by mouse embryos, PIF
detection required large group of embryos to be cul-
tured together. These results confirm the intimate invol-
vement of PIF in embryo development since levels are
higher in cultured blastocysts, as compared with morula.
Thus, the increased peptide levels correlated with a
more advanced developmental stage. In contrast, PIF
was not detected in atretic embryo culture medium.
Given the inherent murine model limitations, multiple
embryos (due to low-level PIF production) were
required to be cultured; which did not permit to estab-
lish individual embryos contribution of PIF secreted into
the medium. To overcome this limitation, culturing sin-
gle bovine IVF embryos enabled to directly correlate PIF
levels (within the same embryo) with development up to
the blastocyst stage. As expected, in failed bovine
embryos, (those that degenerate), levels were similar to
non-cleaving embryos alone (assay background levels).
From these findings, PIF emerges as an early, reliable,
and non-invasive embryo-specific viability marker which
could improve IVF success rates without the need to
culture embryos up to the blastocyst stage before trans-
fer to the maternal host. This is likely since in the mod-
els used, PIF levels in embryos were determined in
sequential cultures. Thus, early detection of PIF pre-
dicted a further progress in embryo development. PIF-
ELISA method is easy to implement and results are
a v a i l a b l ei n< 3h o u r s .A n dt h ea s s a yi sh i g h l ys p e c i f i c
since the antibody does not cross-react with scrambled
PIF, and the monoclonal antibody is highly potent.
We view that the data from single bovine embryo cul-
ture provides the evidence that PIF secretion increases
with developmental stage, and therefore implementation
for human IVF setting may be valuable. Thereby, PIF-
based testing could be a valuable marker for assessing
embryo viability in the medium, reducing the need for
multi-embryo transfer. Preliminary evidence in that
respect has been recently generated in women using an
anti-PIF antibody-based immunoassay where detection
in singly cultured embryo culture medium correlated
with live birth post-multiple embryo transfer. Also more
recently, no pregnancy has resulted following the trans-
fer of single PIF negative embryos in women following
IVF [23,24].
Since PIF is already secreted by the post-fertilization
e m b r y o ,t h ep o s s i b l er o l eo ft h ep e p t i d ei nm o d u l a t i n g
its own development was also examined. It was found
that endogenous PIF levels are directly associated with
embryo viability since adding of anti-PIF-mAb to the
medium at the 2-cell stage markedly inhibited mouse
embryo development, leading most frequently to their
demise. Therefore, embryo-secreted PIF likely exerts an
supportive role on embryo development starting shortly
post-fertilization.
Hence, in our view the embryo emerges as a semi-
autonomic entity that operates within the maternal
milieu and PIF plays an essential role in promoting this
relative independence. This is especially relevant during
the period when the embryo is surrounded by the zona
pellucida that may limit the access of trophic agents
from the maternal host. Since the expression of the
majority of embryo-derived compounds is lower post-
fertilization, it is remarkable that PIF would be secreted
shortly post-fertilization and its expression will continue
also throughout pregnancy [12]. The use of a non-speci-
f i cm o n o c l o n a la n t i b o d ya sn e g a t i v ec o n t r o lt h a tf a i l e d
to affect embryo survival, verified that the anti-PIF-mAb
effect was specific.
The anti-PIF-mAb data raises the question: how does
PIF exert its embryo-trophic effect and whether the
effect is direct or indirect. We found that FITC-PIF is
being taken-up by the cultured cow blastocyst, which
implies the presence of an autocrine loop. This might
also explain the data generated using anti-PIF-mAb to
inhibit embryo development. Where a break in this
autocrine loop (the secreted PIF is not being taken-up)
has led to the arrested embryo development. The identi-
fication of endogenous sites within the embryo where
PIF interacts is an active area of investigation. To docu-
ment binding specificity, two different stains were per-
formed. The DAPI stain documented that cells were
intact and nucleus is well preserved. Then images were
superimposed with FITC-PIF staining. The data showed
progressive change in location of FITC-PIF as the blas-
tocyst has expanded (polarization?). The finding that the
labeled scrambled PIF failed to bind reflects PIF
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PIF uptake in culture mouse blastocysts were observed
where a similar polarization was observed. (unpublished).
This suggests that in both species an autocrine loop is
present, which may have a role in supporting embryo
development shortly post-fertilization. Support for PIF’s
autocrine trophic role was recently documented in singly
cultured bovine embryos when addition of sPIF for the
first three days increased the number of embryos reach-
ing up to the blastocyst stage at day 7 [25].
This study is limited although FITC-PIF binding to
blastocysts was demonstrated, the specific sites of inter-
action were not precisely identified. Strengths of the
research are the use of a specific sensitive monoclonal
antibody-based PIF-ELISA that enables detection of low
PIF levels and the use of two different mammalian spe-
cies for embryo culture evaluation.
Previously, it was reported that culturing embryos in
groups promote their development through a possible
“cross talk”. In addition, other possible supportive sig-
nals in embryos have been reported [26-30]. Our work
clearly suggests that PIF has an important autocrine
trophic cross-talk role.
Conclusions
In conclusion, endogenous PIF is required for embryo
development and the supportive effects of the peptide
are exerted directly on the embryo. Our observations
add a novel facet for PIF secreted by the post-fertiliza-
tion embryos; complementing the peptide’s global role.
Whereby, the embryo is controlling its own destiny by
creating a favorable environment to enhance its develop-
ment. PIF-ELISA is established as a valuable tool for PIF
detection in culture medium of mammalian embryos
reflecting on and correlating with their viability and pro-
gress to later stages of development and possible subse-
quent pregnancy success. The use of PIF measurements
to improve embryo selection for transfer post-IVF is
warranted and is currently being implemented in multi-
center studies.
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